The Effect of Estrogen in the Prevention of Adhesion Reformation after Hysteroscopic Adhesiolysis: A Prospective Randomized Control Trial

J Minim Invasive Gynecol. 2022 Jul;29(7):871-878. doi: 10.1016/j.jmig.2022.04.004. Epub 2022 Apr 16.

Abstract

Study objective: To evaluate whether estrogen therapy can reduce adhesion reformation after hysteroscopic adhesiolysis.

Design: A single-center, single blinded, randomized controlled trial.

Setting: A tertiary University Hospital.

Patients: A total of 207 patients with mild (American Fertility Society [AFS] score 1-6) and severe (AFS score 7-12) intrauterine adhesion who underwent hysteroscopic adhesiolysis.

Interventions: Patients were randomized to a treatment group or a control group, stratified according to the preoperative AFS adhesion score. The treatment group received estrogen, and the control group did not. All patients had second-look hysteroscopy at 4 weeks and third-look hysteroscopy at 8 weeks after surgery.

Measurements and main results: Primary outcome measures were adhesion reformation rate and AFS score at third-look hysteroscopy. Secondary outcome measures included adhesion reformation rate and AFS score at second-look hysteroscopy and menstrual pattern improvement rate at 3 months after operation. Among subjects with mild intrauterine adhesion, there was no significant difference between the treatment group and control group with regard to adhesion reformation rate at third-look hysteroscopy (10.6% vs 13.6%), AFS score (mean ± standard deviation) at third-look hysteroscopy (1.1 ± 1.2 vs 1.3 ± 1.2), and menstrual pattern improvement rate at 3-month follow-up (89.4% vs 86.4%). Similarly, among those with severe intrauterine adhesion, there was no significant difference between the treatment group and control group in adhesion reformation rate at third-look hysteroscopy (32.6% vs 26.7%), AFS score (mean ± standard deviation) at third-look hysteroscopy (2.5±2.2 vs 2.7±2.1), and menstrual pattern improvement rate at 3-month follow-up (84.8% vs 73.3%).

Conclusion: Postoperative estrogen therapy did not appear to reduce the incidence or severity of adhesion reformation, nor did it improve the menstrual pattern, regardless of whether the pre-existing intrauterine adhesion was mild or severe.

Keywords: AFS score; Estrogen; Hysteroscopic adhesiolysis; Intrauterine adhesion.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Estrogens / therapeutic use
  • Female
  • Humans
  • Hysteroscopy* / adverse effects
  • Pregnancy
  • Prospective Studies
  • Tissue Adhesions / etiology
  • Tissue Adhesions / prevention & control
  • Tissue Adhesions / surgery
  • Uterine Diseases* / complications

Substances

  • Estrogens